Early Outcomes of Darunavir- and/or Raltegravir-Based Antiretroviral Therapy in Children with Multidrug-Resistant HIV at a Pediatric Center in Botswana

Early Outcomes of Darunavir- and/or Raltegravir-Based Antiretroviral Therapy in Children with Multidrug-Resistant HIV at a Pediatric Center in Botswana

Background: Data on the use of ritonavir-boosted darunavir (DRV/r) and/or raltegravir (RAL) in resource-limited settings are rare and there is currently no published data regarding their use among African children. Botswana has recently made DRV/r and RAL available for patients failing second-line a...

Full description

Bibliographic Details
Main Authors: Brianna L. Kirk MD, Andres Gomila MD, Mogomotsi Matshaba MD, Marape Marape MBBCh, BAO, MPH, PhD, Dipesalema R. Joel MBBCh, BAO, BMedSc, MRCP, Gabriel Anabwani MD, Michael A. Tolle MD, MPH
Format: Article
Language:English
Published: SAGE Publishing 2013-03-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/1545109712463073

Internet

https://doi.org/10.1177/1545109712463073

Similar Items